![]() |
Name |
(5Z)-3-(2,2-dimethyl-3,4-dihydrochromen-6-yl)-4-hydroxy-5-[(7-hydroxy-2,2-dimethyl-3,4-dihydrochromen-6-yl)methylidene]furan-2-one
|
Molecular Formula | C27H28O6 | |
IUPAC Name* |
(5Z)-3-(2,2-dimethyl-3,4-dihydrochromen-6-yl)-4-hydroxy-5-[(7-hydroxy-2,2-dimethyl-3,4-dihydrochromen-6-yl)methylidene]furan-2-one
|
|
SMILES |
CC1(CCC2=CC(=C(C=C2O1)O)/C=C\3/C(=C(C(=O)O3)C4=CC5=C(C=C4)OC(CC5)(C)C)O)C
|
|
InChI |
InChI=1S/C27H28O6/c1-26(2)9-7-15-11-17(5-6-20(15)32-26)23-24(29)22(31-25(23)30)13-18-12-16-8-10-27(3,4)33-21(16)14-19(18)28/h5-6,11-14,28-29H,7-10H2,1-4H3/b22-13-
|
|
InChIKey |
XLEVGQVQFXMEHD-XKZIYDEJSA-N
|
|
Synonyms |
Aspulvinone C; 55215-35-5
|
|
CAS | NA | |
PubChem CID | 90473410 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 448.5 | ALogp: | 4.9 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 85.2 | Aromatic Rings: | 5 |
Heavy Atoms: | 33 | QED Weighted: | 0.576 |
Caco-2 Permeability: | -5.372 | MDCK Permeability: | 0.00001770 |
Pgp-inhibitor: | 1 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.019 | 20% Bioavailability (F20%): | 0.999 |
30% Bioavailability (F30%): | 0.947 |
Blood-Brain-Barrier Penetration (BBB): | 0.084 | Plasma Protein Binding (PPB): | 99.97% |
Volume Distribution (VD): | 0.43 | Fu: | 0.85% |
CYP1A2-inhibitor: | 0.228 | CYP1A2-substrate: | 0.834 |
CYP2C19-inhibitor: | 0.797 | CYP2C19-substrate: | 0.383 |
CYP2C9-inhibitor: | 0.834 | CYP2C9-substrate: | 0.953 |
CYP2D6-inhibitor: | 0.266 | CYP2D6-substrate: | 0.653 |
CYP3A4-inhibitor: | 0.863 | CYP3A4-substrate: | 0.582 |
Clearance (CL): | 2.956 | Half-life (T1/2): | 0.062 |
hERG Blockers: | 0.019 | Human Hepatotoxicity (H-HT): | 0.757 |
Drug-inuced Liver Injury (DILI): | 0.359 | AMES Toxicity: | 0.022 |
Rat Oral Acute Toxicity: | 0.286 | Maximum Recommended Daily Dose: | 0.909 |
Skin Sensitization: | 0.108 | Carcinogencity: | 0.364 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.011 |
Respiratory Toxicity: | 0.568 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002804 | ![]() |
0.525 | D06GCK | ![]() |
0.258 | ||
ENC002561 | ![]() |
0.402 | D0K8KX | ![]() |
0.246 | ||
ENC003492 | ![]() |
0.353 | D05HSC | ![]() |
0.243 | ||
ENC005411 | ![]() |
0.344 | D06TJJ | ![]() |
0.242 | ||
ENC005410 | ![]() |
0.336 | D04AIT | ![]() |
0.240 | ||
ENC003373 | ![]() |
0.333 | D0L1JW | ![]() |
0.237 | ||
ENC002800 | ![]() |
0.305 | D0N0RU | ![]() |
0.237 | ||
ENC002900 | ![]() |
0.304 | D07MGA | ![]() |
0.234 | ||
ENC000919 | ![]() |
0.302 | D02PMO | ![]() |
0.228 | ||
ENC004156 | ![]() |
0.297 | D0Z4XW | ![]() |
0.226 |